第17回がん専門医ダイレクトライブ「膵がんのこと、正しく知っていますか?」20251012

第17回がん専門医ダイレクトライブ「膵がんのこと、正しく知っていますか?」20251012

Life & Natural Systems Medicine & Health VFJBCoping with
🎙 がんチューブ (一般社団法人日本癌治療学会) 👥 5K 📅 October 12, 2025 ⏱ 122 min 👁 20K 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

pancreatic cancerconversion surgeryFOLFIRINOXCA19-9second opinion

Summary

This live session, organized by the Japanese Society of Medical Oncology, focuses on pancreatic cancer. Prof. Fujii from Toyama University delivers a keynote lecture covering the basics: anatomy, symptoms, risk factors, and the importance of early detection. He emphasizes that symptoms like abdominal pain, jaundice, and sudden diabetes worsening warrant prompt investigation. The lecture highlights the poor prognosis of pancreatic cancer (5-year survival ~8.5% for 2009-2011 diagnoses) but notes improvements with modern chemotherapy. A key topic is conversion surgery, where initially unresectable tumors become resectable after effective chemotherapy, with Toyama’s data showing 5-year survival around 60%. The session includes a survivor, Mizuki, who shares her journey and treatment. The Q&A segment addresses questions on tumor markers (CA19-9 can be normal in 10% of Japanese patients), side effects of FOLFIRINOX, hereditary pancreatic cancer, complementary therapies, and postoperative adjuvant chemotherapy. The doctors also clarify the meaning of ‘median survival’ to prevent misinterpretation. The event concludes with a strong warning against unproven internet remedies.

161 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides substantial value by delivering accurate, up-to-date information on pancreatic cancer directly from a specialist. The argumentation is solid, grounded in clinical experience and published data (e.g., survival statistics, surgical outcomes). The inclusion of a survivor’s perspective adds practical insight and emotional resonance. The doctors carefully explain complex concepts (e.g., CA19-9 limitations, conversion surgery) in an accessible manner, and they explicitly debunk common myths, enhancing the educational value.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high: the speaker is a professor of surgery and a guideline committee member, and the content aligns with current Japanese guidelines. The video cites specific data (e.g., 5-year survival from Cancer Statistics 2024) and references the Japan Pancreas Society for finding specialists. The title accurately reflects the content. No comments were provided for analysis.

143 words

Title / Content Match

The title accurately reflects the content: a live Q&A session with a pancreatic cancer specialist, aiming to educate the public about pancreatic cancer.

Quality & Reliability

9/10

The video features a board-certified pancreatic surgeon (Prof. Fujii) and a cancer survivor, providing evidence-based information on pancreatic cancer. The content aligns with established medical guidelines, and the speakers explicitly debunk common myths. The presence of a disclaimer about unsupported ads further enhances credibility.

Chapters

Cited Sources

Concurring Sources

  • Pancreatic cancer - Mayo Clinic — General information on symptoms and risk factors, consistent with the video.

Contribution & Novelties

The video offers a unique format: a live, interactive session where a specialist and a survivor directly answer public questions, bridging the gap between expert knowledge and patient experience. It provides practical guidance on recognizing warning signs, understanding treatment options, and navigating the healthcare system. The emphasis on conversion surgery and the clarification of median survival are particularly valuable.

Pour aller plus loin :

105 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and reliability, with a slightly lower technical level, reflecting the video's balance between expert depth and accessibility for a general audience.

Reliability 9/10